NBIX logo

Neurocrine Biosciences, Inc. (NBIX) Retained Earnings

Annual Retained Earnings:

$29.20M+$186.30M(+118.59%)
December 31, 2024

Summary

  • As of today, NBIX annual retained earnings is $29.20 million, with the most recent change of +$186.30 million (+118.59%) on December 31, 2024.
  • During the last 3 years, NBIX annual retained earnings has risen by +$665.00 million (+104.59%).
  • NBIX annual retained earnings is now at all-time high.

Performance

NBIX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Quarterly Retained Earnings:

$84.50M+$89.80M(+1694.34%)
June 30, 2025

Summary

  • As of today, NBIX quarterly retained earnings is $84.50 million, with the most recent change of +$89.80 million (+1694.34%) on June 30, 2025.
  • Over the past year, NBIX quarterly retained earnings has increased by +$133.20 million (+273.51%).
  • NBIX quarterly retained earnings is now at all-time high.

Performance

NBIX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

NBIX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+118.6%+273.5%
3Y3 Years+104.6%+115.0%
5Y5 Years+102.6%+108.3%

NBIX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+104.6%at high+117.0%
5Y5-Yearat high+102.6%at high+107.9%
All-TimeAll-Timeat high+102.4%at high+106.6%

NBIX Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
$84.50M(+1694.3%)
Mar 2025
-
-$5.30M(-118.2%)
Dec 2024
$29.20M(+118.6%)
$29.20M(-64.0%)
Sep 2024
-
$81.10M(+266.5%)
Jun 2024
-
-$48.70M(+57.2%)
Mar 2024
-
-$113.70M(+27.6%)
Dec 2023
-$157.10M(+61.4%)
-$157.10M(+48.5%)
Sep 2023
-
-$304.80M(+21.4%)
Jun 2023
-
-$387.90M(+19.8%)
Mar 2023
-
-$483.40M(-18.8%)
Dec 2022
-$406.80M(+36.0%)
-$406.80M(+18.0%)
Sep 2022
-
-$495.80M(+12.1%)
Jun 2022
-
-$564.30M(-3.1%)
Mar 2022
-
-$547.40M(+13.9%)
Dec 2021
-$635.80M(+12.4%)
-$635.80M(-1.2%)
Sep 2021
-
-$628.50M(+3.5%)
Jun 2021
-
-$651.00M(+6.1%)
Mar 2021
-
-$693.30M(+4.4%)
Dec 2020
-$725.40M(+36.0%)
-$725.40M(+32.4%)
Sep 2020
-
-$1.07B(-5.7%)
Jun 2020
-
-$1.02B(+7.3%)
Mar 2020
-
-$1.10B(+3.3%)
Dec 2019
-$1.13B(+3.8%)
-$1.13B(+2.9%)
Sep 2019
-
-$1.17B(+4.4%)
Jun 2019
-
-$1.22B(+4.0%)
Mar 2019
-
-$1.27B(-8.0%)
Dec 2018
-$1.18B(+1.8%)
-$1.18B(+1.5%)
Sep 2018
-
-$1.20B(+4.1%)
Jun 2018
-
-$1.25B(-0.5%)
Mar 2018
-
-$1.24B(-3.5%)
Dec 2017
-$1.20B(-13.5%)
-$1.20B(+0.6%)
Sep 2017
-
-$1.21B(-0.9%)
Jun 2017
-
-$1.19B(-5.3%)
Mar 2017
-
-$1.13B(-7.4%)
Dec 2016
-$1.06B(-15.4%)
-$1.06B(-4.4%)
Sep 2016
-
-$1.01B(-3.8%)
Jun 2016
-
-$974.78M(-4.3%)
Mar 2016
-
-$934.50M(-2.1%)
Dec 2015
-$915.23M(-10.8%)
-$915.23M(-3.3%)
Sep 2015
-
-$885.92M(-4.0%)
Jun 2015
-
-$851.48M(-2.9%)
Mar 2015
-
-$827.50M(-0.1%)
Dec 2014
-$826.30M(-7.9%)
-$826.30M(-2.4%)
Sep 2014
-
-$806.86M(-2.0%)
Jun 2014
-
-$790.99M(-1.7%)
Mar 2014
-
-$777.61M(-1.5%)
Dec 2013
-$765.76M(-6.4%)
-$765.76M(-1.4%)
Sep 2013
-
-$755.12M(-1.5%)
Jun 2013
-
-$743.99M(-1.7%)
Mar 2013
-
-$731.75M(-1.7%)
Dec 2012
-$719.67M(+0.7%)
-$719.67M(+1.3%)
Sep 2012
-
-$729.16M(-0.4%)
Jun 2012
-
-$726.09M(-0.1%)
Mar 2012
-
-$725.58M(-0.1%)
Dec 2011
-$724.70M(+4.9%)
-$724.70M(+0.2%)
Sep 2011
-
-$726.03M(+4.1%)
Jun 2011
-
-$757.41M(+0.3%)
Mar 2011
-
-$759.39M(+0.4%)
Dec 2010
-$762.27M
-$762.27M(+0.3%)
DateAnnualQuarterly
Sep 2010
-
-$764.76M(+0.4%)
Jun 2010
-
-$768.09M(-0.7%)
Mar 2010
-
-$762.94M(-1.1%)
Dec 2009
-$754.30M(-7.3%)
-$754.30M(-1.1%)
Sep 2009
-
-$746.38M(-1.1%)
Jun 2009
-
-$738.21M(-2.1%)
Mar 2009
-
-$722.93M(-2.8%)
Dec 2008
-$703.26M(-14.4%)
-$703.26M(-4.3%)
Sep 2008
-
-$674.41M(-2.7%)
Jun 2008
-
-$656.70M(-3.3%)
Mar 2008
-
-$635.73M(-3.4%)
Dec 2007
-$614.65M(-50.9%)
-$614.65M(-26.3%)
Sep 2007
-
-$486.68M(-5.9%)
Jun 2007
-
-$459.44M(-6.1%)
Mar 2007
-
-$433.07M(-6.3%)
Dec 2006
-$407.35M(-35.7%)
-$407.35M(-3.7%)
Sep 2006
-
-$392.64M(-11.1%)
Jun 2006
-
-$353.50M(-8.4%)
Mar 2006
-
-$326.05M(-8.6%)
Dec 2005
-$300.15M(-8.0%)
-$300.15M(-8.7%)
Sep 2005
-
-$276.24M(+8.6%)
Jun 2005
-
-$302.39M(-1.9%)
Mar 2005
-
-$296.79M(-6.8%)
Dec 2004
-$277.95M(-19.7%)
-$277.95M(-8.0%)
Sep 2004
-
-$257.34M(-0.6%)
Jun 2004
-
-$255.69M(-4.6%)
Mar 2004
-
-$244.56M(-5.3%)
Dec 2003
-$232.18M(-15.0%)
-$232.18M(+1.4%)
Sep 2003
-
-$235.38M(-4.4%)
Jun 2003
-
-$225.54M(-4.7%)
Mar 2003
-
-$215.32M(-6.6%)
Dec 2002
-$201.93M(-88.0%)
-$201.93M(-23.8%)
Sep 2002
-
-$163.14M(-14.2%)
Jun 2002
-
-$142.91M(-16.0%)
Mar 2002
-
-$123.15M(-14.7%)
Dec 2001
-$107.39M(-52.4%)
-$107.39M(-15.7%)
Sep 2001
-
-$92.78M(+2.6%)
Jun 2001
-
-$95.29M(-16.3%)
Mar 2001
-
-$81.94M(-16.3%)
Dec 2000
-$70.48M(-69.0%)
-$70.48M(-15.5%)
Sep 2000
-
-$61.05M(-15.4%)
Jun 2000
-
-$52.91M(-10.9%)
Mar 2000
-
-$47.72M(-14.4%)
Dec 1999
-$41.70M(-67.5%)
-$41.70M(-9.7%)
Sep 1999
-
-$38.00M(-13.4%)
Jun 1999
-
-$33.50M(-15.9%)
Mar 1999
-
-$28.90M(-16.1%)
Dec 1998
-$24.90M(-408.2%)
-$24.90M(-37.6%)
Sep 1998
-
-$18.10M(-28.4%)
Jun 1998
-
-$14.10M(-131.1%)
Mar 1998
-
-$6.10M(-24.5%)
Dec 1997
-$4.90M(+51.0%)
-$4.90M(+2.0%)
Sep 1997
-
-$5.00M(+13.8%)
Jun 1997
-
-$5.80M(+1.7%)
Mar 1997
-
-$5.90M(+41.0%)
Dec 1996
-$10.00M
-$10.00M(+31.0%)
Sep 1996
-
-$14.50M(-2.8%)
Jun 1996
-
-$14.10M(+11.3%)
Mar 1996
-
-$15.90M

FAQ

  • What is Neurocrine Biosciences, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. annual retained earnings year-on-year change?
  • What is Neurocrine Biosciences, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. quarterly retained earnings year-on-year change?

What is Neurocrine Biosciences, Inc. annual retained earnings?

The current annual retained earnings of NBIX is $29.20M

What is the all-time high annual retained earnings for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high annual retained earnings is $29.20M

What is Neurocrine Biosciences, Inc. annual retained earnings year-on-year change?

Over the past year, NBIX annual retained earnings has changed by +$186.30M (+118.59%)

What is Neurocrine Biosciences, Inc. quarterly retained earnings?

The current quarterly retained earnings of NBIX is $84.50M

What is the all-time high quarterly retained earnings for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high quarterly retained earnings is $84.50M

What is Neurocrine Biosciences, Inc. quarterly retained earnings year-on-year change?

Over the past year, NBIX quarterly retained earnings has changed by +$133.20M (+273.51%)
On this page